SCHEMBL8278581

SCHEMBL8278581

CC(C)(C)OC(=O)NC(CC1CCNC1=O)C(=O)CBr

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8276856 1.00 — —
SCHEMBL24754878 0.93 CTSS (0.39) —
SCHEMBL24710112 0.89 CTSL (0.44) —
SCHEMBL29179605 0.89 CTSL (0.44) —
SCHEMBL24755492 0.89 CTSL (0.44) —
SCHEMBL23824539 0.88 CTSL (0.41) —
SCHEMBL30248405 0.88 — —
SCHEMBL8278850 0.88 CTSL (0.41) —
SCHEMBL24190098 0.88 — —
SCHEMBL23824538 0.88 CTSL (0.41) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022261473-A1 PROTEASE INHIBITORS FOR THE TREATMENT OF CORONAVIRUS INFECTIONS THE SCRIPPS RESEARCH INSTITUTE (US) 2022-12-15 — — WO disclosed
WO-2005113580-A1 ANTICORONVIRAL COMPOUNDS AND COMPOSITIONS, THEIR PHARMACEUTICAL USES AND MATERIALS FOR THEIR SYNTHESIS PFIZER INC. (US) 2005-12-01 — — WO disclosed
Send feedback